Keywords: Pharmaceutical executives, Commercial business models, Cegedim Dendrite

35% of pharmaceutical executives in the USA concerned over changing commercial business models, survey reveals

Article | 16 July 2010

Customer relationship management company Cegedim Dendrite says that its 2010 Insights Survey found that 35% of respondents saw changing commercial business models ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in